The SCOUT MD TM Surgical Guidance System, inclusive of the SCOUT MD TM Delivery System, has a Breakthrough Device designation effective February 1, 2023, and marketing authorization from FDA effective February 12, 2024, for the indication covered by the Breakthrough Device designation
Please note: The FDA does not verify the safety or effectiveness of compounded medications
Before commencing IV therapy, certain precautions should be observed
Draw up slightly more than needed, then adjust to the exact dose after removing air bubbles
Its the simplest, most accessible thing we do and for the right patient, its also one of the most genuinely felt
Promotes Healthy Bones B12 can promote healthy bones and keep your body more robust and more agile overall